Services
Inquiry and ordering
Yeast One Hybrid Service
TekBiotech is committed to providing technical development services for brand-new drug antibodies and targeted peptide drugs. We have built a complete yeast surface display technology system. After years of project accumulation, combined with our experience in targeted peptide screening (cell screening, in vivo screening in animals), we have specially launched a system for discovering and verifying interactions at the intracellular level, namely the yeast hybridization verification system. To simplify, we use the improved SMART technology to build cDNA yeast libraries for customers and provide a series of derived yeast hybridization verification services.
█ Basic Principles of Yeast One-hybrid Technology
When scientists are studying the regulatory elements of specific genes - cis-acting elements: promoters, enhancers and silencers (collectively referred to as: cis-acting elements), which unknown proteins can bind to the cis-acting elements and trigger the transcription and expression of the genes corresponding to the cis-acting elements. Based on the above needs, the yeast one-hybrid (Y1H) system can complete this verification. As shown in Figure 1, in the yeast one-hybrid system, the transcription factor GAL4 acts like a bridge. The basic principle is that the transcription factor GAL4 can regulate the expression of yeast galactosidase gene. When yeast expresses galactosidase, galactosidase catalyzes X-gal to produce blue colonies on the plate containing X-gal.
The transcription factor GAL4 contains two domains that can function independently: the transcription activation domain (AD) and the DNA binding domain (BD). The library containing various cDNA sequences is cloned into the expression vector with GAL4-AD to form vector 1; the cis-acting element is cloned into the vector with GAL4-BD to form vector 2. Then vector 1 and vector 2 are transformed into the same yeast cell for co-expression: if the fusion protein expressed by cDNA-GAL4-AD in vector 1 can bind to the cis-acting element in vector 2, the AD of GAL4 in vector 1 and the BD in vector 2 will combine to form a complete transcription factor GAL4, and GAL4 will bind to the upstream of the galactosidase gene, prompting the expression of the galactosidase gene to produce enzyme activity catalysis (i.e., reporter gene).
Figure 1 Principle of Yeast Single Hybrid Technology
The library capacity of the yeast single hybrid cDNA library constructed by Tekbiotech can reach 10^7-10^8, and the library diversity and insertion rate can reach more than 90%, meeting the quality requirements of various customers for yeast single hybrid libraries. At the same time, TekBiotech can also provide one-stop technical services such as downstream gene synthesis and affinity determination verification for yeast single-hybrid library construction and screening. Customers only need to provide specific target gene DNA sequence information (cis-acting element/promoter sequence to be studied), library type to be constructed and sample information. TekBiotech scientists can design reasonable solutions and customize them according to customer needs, helping customers' scientific research projects and the discovery of targeted interacting proteins/new transcription factors.
█ Experimental Types Applicable to Yeast Single-hybrid Technology
Table 1 Common Verification Types of Yeast One-hybrid | |
Whether there is an interaction between known DNA and unknown proteins | Discover new genes that bind to cis-acting elements |
Locate the DNA binding domain of confirmed DNA-binding proteins | DNA binding corresponding base sequence |
█ Yeast One-hybrid Service Content and Cycle
Steps | Service Content | Cycle |
Option 1: Yeast One-hybrid Library Construction | 1) Total RNA extraction (+ mRNA purification preparation); 2) High-fidelity RT-PCR preparation of cDNA; 3) Vector construction and transformation: vector construction (cDNA connected to yeast single-hybrid vector: fusion AD) + electroporation transformation of yeast strains; 4) Plate picking of positive clones + PCR amplification of positive clones (gel identification) + WB expression verification (if the customer allows the addition of tags) + library NGS sequencing; 5) Delivery: 1 tube of yeast library plasmid (>500ug), 10-20ml yeast library glycerol bacteria, experimental report; | 4-6 Weeks |
Option 2: Yeast One-hybrid Library Screening | 1) Self-activation verification; 2) Target gene DNA (cis-acting element or promoter)-BD fusion plasmid and library plasmid co-transformed into yeast strain; 3) Yeast screening; 4) Sequencing of screening results + back-transformation verification; 5) Delivery: experimental report, sequencing raw data; | 3-5 Weeks |
█ Yeast One-hybrid Platform Service Advantages
Mature platform, fast cycle | High cost-effectiveness, guaranteed experimental results | Large library capacity, high diversity | Experimental records are traceable: library QC quality control standards, Chinese and English experimental reports, original experimental records |
The yeast one-hybrid (Y1H) system enables the identification of proteins that can bind to DNA elements of interest, including cis-regulatory elements, origins of DNA replication, and telomeres. In the Y1H system, using a single hybrid protein AD-Y, reporter gene expression is activated when Y interacts with the DNA bait. Although many of the predicted regulatory TF contain intrinsic AD, some TF have a repressor domain or no activation / repressor domain at all. In addition, DNA-binding proteins that do not function in transcription (e. g., replication and DNA repair proteins) do not contain AD. To be able to identify various DNA binding proteins, strong heterologous AD was added to the prey proteins. To facilitate the high-throughput, unbiased identification of protein – DNA interactions, we have developed a Y1H system compatible with Gateway. This system can be used for small copies (e. g. cis-regulatory elements) and single copies of large DNA fragments (e. g. gene promoters). In many cases, DNA binding proteins are often regulated by the recruitment of accessory proteins. Most of bZIP and bHLH, families, such as Jun-Fos, Myc-Max as well as classical phage λ repressor and Cro proteins, belong to this class of transcription factors. Many yeast genetic methods have been reported to study proteins in complexes with known chaperones to form heterodimeric complexes that bind DNA; these complexes may include a chaperone that lacks intrinsic DNA binding capacity through dimerization with accessory proteins. Traditionally, these studies have used two separate plasmids to express two different proteins. Researchers have developed a plasmid-based modified Y1H system (MY 1 H). In addition to the AD fusion protein, the second protein was also co-expressed at comparable or excess levels.
The yeast one-hybrid system (Y1H) provides one of the few direct strategies, often used to identify transcription factor (TF) -promoter interactions, with a focus on individual promoter regions. This method requires two main components: a reporter construct (bait) that carries a promoter region (e. g. lacZ), usually integrated into the genome of the yeast strain (such as YM4271) and an effector construct (prey) driving the expression of a TF (Gal 4-AD) (AD). After converting the effector constructs into reporter strains, increased reporter activity revealed TF-promoter interactions depending on the DNA binding affinity and specificity of the TF-AD effectors for the promoter baits. Following the initial design, the effector constructs used for Y1H screening were part of the cDNA library. These cDNA libraries provide only partial and biased libraries of potential DNA binding proteins. With the era, some efforts have been made to develop global TF effector libraries for different species. Adjusting the Y1H system to these TF ORFeome clone collections significantly improved the method, enhancing the discovery of functional TF-promoter interactions in an unbiased and comprehensive manner.Overall, the yeast one-hybrid system constructs an expression plasmid for a fusion of a library protein to a transcription activation domain as well as a reporter plasmid, and utilizes biological activity to detect DNA – protein interactions.
Yeast single-hybridization rapidly screens numerous transcription factors and significantly accelerates the research process. With the help of the high-throughput library construction strategy, this technology can cover a wide range of transcription factors, providing a strong support for exploring the regulatory network of specific genes. The experiments were conducted in yeast cells near the natural state, ensuring that the obtained interaction data are highly physiological relevant, thus more accurately reflecting the interaction between protein and DNA in a real cell environment. This technique can not only verify the existence of protein-DNA interactions, but also quantify the strength of interactions by assessing the expression level of reporter genes, opening a way for deep insights into the quantitative features of protein-DNA interactions. The yeast single-hybrid system is easy to operate and standardized, which is easy to be used in various laboratory environments. In addition, yeast cell culture and screening costs are low, so the technology shows good economy. In the regulation of gene expression in eukaryotic cells, yeast one-hybrid technology can be used to identify DNA binding sites, excavate potential binding protein genes, and resolve DNA binding domain information. By monitoring the phenotypic changes in reporter genes, this technique can dissect the interaction between DNA and proteins, and then reveal the mechanism of gene regulation involved in eukaryotic cells. Given the high sensitivity and reliability of the yeast one-hybrid method in detecting specific interactions between specific transcription factors with cis-acting elements, it has become the method of choice for cloning specific transcription factors of low abundance and difficult to purify by biochemical means. The yeast single-hybrid technique can be used to determine whether there are known interactions between DNA and protein. Yeast single-hybrid technology also has potential applications in new drug development. By constructing a yeast one-hybrid system for drug targets, the screening of drug molecules that interact with the target can be screened, providing strong support for new drug development.
The yeast one-hybrid system (Y1H), as a derivative of the yeast two-hybrid system (Y2H), is a versatile and widely used in vivo genetic analysis tool designed to identify interactions between proteins and DNA. Y1H enables not only to isolate protein-coding genes bound to cis-acting elements, but also enables in-depth characterization of known protein – DNA interactions, while the Y2H system focuses on the detection of protein-protein interactions. In the Y2H system, the construction of two hybrid proteins is involved: the bait protein (X) is fused to the DNA binding domain (DB), and the prey protein (Y) is coupled to the transcriptional activation domain (AD). When X and Y physically interact with each other, the functional TF is reconstructed and reporter gene expression is activated. In contrast to Y2H, Y1H directly obtains the nucleotide sequence encoding a protein bound to DNA directly from a gene library without complex protein isolation and purification operations. Provides efficient methods for cloning DNA binding proteins that facilitate the identification of proteins that interact with specific DNA sequences. Has unique advantages in studying the expression regulation of genes within eukaryotic cells.In conclusion, the yeast one-hybrid system and the yeast two-hybrid system each have their own unique principles and advantages, and which system selection depends on the specific research purpose and experimental conditions.
In yeast one-hybrid experiments, we encounter bait protein functions that may be impaired by truncation. Insufficient chemical conversion or electroconversion efficiency, and too few or too many positive clones. Facing the above problems, TEK Biotech ensured that the number of clones screened was greater than 1 million. TEK Biotech adjusted AbA inhibitory concentration, such as increased from 100 ng / ml to 200 ng/ml rescreen.When performing the interception of transcription activation region, the operation should be careful to prevent the interaction results. At the same time, the application of 3 ′ AT or ABA can be considered to inhibit the background signals, but we should be alert to the possible toxic effects of these two chemical reagents on yeast growth. In terms of chemical transformation, TEK Biotech ensures that the transformation efficiency of competent cells is not less than 10 ^ 4, and one way to improve the transformation efficiency is to increase the amount of oxygen of competent cells, the specific operation is to control the amount of liquid not more than one fifth of the volume of the container. As for the electrical conversion, it adds 10% glycerol to preserve the competent cells, and sets the conversion parameters to 800 volts and 15 ms, so that the conversion efficiency can be up to 10 ^ 5 to 10 ^ 6 times.
To experience the reliable service of Tekbiotech please subscribe:
Antibody Discovery
Antibody Production
Antibody Modification
Contact
WeChat Official Account
Technical Support
©2025Tekbiotech (Tianjin) Co., Ltd津ICP备2021009144号-1津公网安备12011402001524号